These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

236 related articles for article (PubMed ID: 12473381)

  • 1. Reversal of P-glycoprotein-mediated multidrug resistance by ginsenoside Rg(3).
    Kim SW; Kwon HY; Chi DW; Shim JH; Park JD; Lee YH; Pyo S; Rhee DK
    Biochem Pharmacol; 2003 Jan; 65(1):75-82. PubMed ID: 12473381
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Modulation of P-glycoprotein expression and function by curcumin in multidrug-resistant human KB cells.
    Anuchapreeda S; Leechanachai P; Smith MM; Ambudkar SV; Limtrakul PN
    Biochem Pharmacol; 2002 Aug; 64(4):573-82. PubMed ID: 12167476
    [TBL] [Abstract][Full Text] [Related]  

  • 3. P-glycoprotein substrates and antagonists cluster into two distinct groups.
    Scala S; Akhmed N; Rao US; Paull K; Lan LB; Dickstein B; Lee JS; Elgemeie GH; Stein WD; Bates SE
    Mol Pharmacol; 1997 Jun; 51(6):1024-33. PubMed ID: 9187269
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Reversal by two dihydropyridine compounds of resistance to multiple anticancer agents in mouse P388 leukemia in vivo and in vitro.
    Kiue A; Sano T; Naito A; Inada H; Suzuki K; Okumura M; Kikuchi J; Sato S; Takano H; Kohno K
    Jpn J Cancer Res; 1990 Oct; 81(10):1057-64. PubMed ID: 1977728
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Cellular pharmacokinetic aspects of reversal effect of itraconazole on P-glycoprotein-mediated resistance of anticancer drugs.
    Takara K; Tanigawara Y; Komada F; Nishiguchi K; Sakaeda T; Okumura K
    Biol Pharm Bull; 1999 Dec; 22(12):1355-9. PubMed ID: 10746169
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Selective toxicity of ginsenoside Rg3 on multidrug resistant cells by membrane fluidity modulation.
    Kwon HY; Kim EH; Kim SW; Kim SN; Park JD; Rhee DK
    Arch Pharm Res; 2008 Feb; 31(2):171-7. PubMed ID: 18365686
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Modulation of function of three ABC drug transporters, P-glycoprotein (ABCB1), mitoxantrone resistance protein (ABCG2) and multidrug resistance protein 1 (ABCC1) by tetrahydrocurcumin, a major metabolite of curcumin.
    Limtrakul P; Chearwae W; Shukla S; Phisalphong C; Ambudkar SV
    Mol Cell Biochem; 2007 Feb; 296(1-2):85-95. PubMed ID: 16960658
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Reversal of multidrug resistance by 7-O-benzoylpyripyropene A in multidrug-resistant tumor cells.
    Rho MC; Hayashi M; Fukami A; Obata R; Sunazuka T; Tomoda H; Komiyama K; Omura S
    J Antibiot (Tokyo); 2000 Oct; 53(10):1201-6. PubMed ID: 11132967
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Effect of anthracycline analogs on photolabelling of p-glycoprotein by [125I]iodomycin and [3H]azidopine: relation to lipophilicity and inhibition of daunorubicin transport in multidrug resistant cells.
    Friche E; Demant EJ; Sehested M; Nissen NI
    Br J Cancer; 1993 Feb; 67(2):226-31. PubMed ID: 8094288
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Effects of a new triazinoaminopiperidine derivative on adriamycin accumulation and retention in cells displaying P-glycoprotein-mediated multidrug resistance.
    Léonce S; Pierré A; Anstett M; Pérez V; Genton A; Bizzari JP; Atassi G
    Biochem Pharmacol; 1992 Nov; 44(9):1707-15. PubMed ID: 1360210
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Interaction of the P-glycoprotein multidrug transporter (MDR1) with high affinity peptide chemosensitizers in isolated membranes, reconstituted systems, and intact cells.
    Sharom FJ; Yu X; Lu P; Liu R; Chu JW; Szabó K; Müller M; Hose CD; Monks A; Váradi A; Seprôdi J; Sarkadi B
    Biochem Pharmacol; 1999 Aug; 58(4):571-86. PubMed ID: 10413294
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Prevention of MDR development in leukemia cells by micelle-forming polymeric surfactant.
    Sharma AK; Zhang L; Li S; Kelly DL; Alakhov VY; Batrakova EV; Kabanov AV
    J Control Release; 2008 Nov; 131(3):220-7. PubMed ID: 18722489
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Polyaromatic alkaloids from marine invertebrates as cytotoxic compounds and inhibitors of multidrug resistance caused by P-glycoprotein.
    Quesada AR; García Grávalos MD; Fernández Puentes JL
    Br J Cancer; 1996 Sep; 74(5):677-82. PubMed ID: 8795567
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Reversal of P-glycoprotein-mediated multidrug resistance by protopanaxatriol ginsenosides from Korean red ginseng.
    Choi CH; Kang G; Min YD
    Planta Med; 2003 Mar; 69(3):235-40. PubMed ID: 12677527
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Vinflunine (20',20'-difluoro-3',4'-dihydrovinorelbine), a novel Vinca alkaloid, which participates in P-glycoprotein (Pgp)-mediated multidrug resistance in vivo and in vitro.
    Etievant C; Barret JM; Kruczynski A; Perrin D; Hill BT
    Invest New Drugs; 1998; 16(1):3-17. PubMed ID: 9740539
    [TBL] [Abstract][Full Text] [Related]  

  • 16. N-(p-azido-3-[125I]iodophenethyl)spiperone binds to specific regions of P-glycoprotein and another multidrug binding protein, spiperophilin, in human neuroblastoma cells.
    Safa AR; Agresti M; Bryk D; Tamai I
    Biochemistry; 1994 Jan; 33(1):256-65. PubMed ID: 7904476
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Circumvention of multidrug resistance by a newly synthesized quinoline derivative, MS-073.
    Sato W; Fukazawa N; Suzuki T; Yusa K; Tsuruo T
    Cancer Res; 1991 May; 51(9):2420-4. PubMed ID: 1673087
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Inhibition of P-glycoprotein-dependent multidrug resistance by an isoquinolinesulfonamide compound H-87 in rat ascites hepatoma AH66 cells.
    Nakamura S; Minamino T; Nomura M; Wakusawa S; Miyamoto K; Hidaka H
    Biol Pharm Bull; 1996 Jun; 19(6):886-9. PubMed ID: 8799494
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Development of novel reversal agents, imidazothiazole derivatives, targeting MDR1- and MRP-mediated multidrug resistance.
    Naito S; Koike K; Ono M; Machida T; Tasaka S; Kiue A; Koga H; Kumazawa J
    Oncol Res; 1998; 10(3):123-32. PubMed ID: 9700723
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Effects of the selective bisindolylmaleimide protein kinase C inhibitor GF 109203X on P-glycoprotein-mediated multidrug resistance.
    Gekeler V; Boer R; Uberall F; Ise W; Schubert C; Utz I; Hofmann J; Sanders KH; Schächtele C; Klemm K; Grunicke H
    Br J Cancer; 1996 Sep; 74(6):897-905. PubMed ID: 8826855
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 12.